The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Continuing challenges in influenza
Open accessAbstract
Influenza is an acute respiratory disease in mammals and domestic poultry that emerges from zoonotic reservoirs in aquatic birds and bats. Although influenza viruses are among the most intensively studied pathogens, existing control options require further improvement. Influenza vaccines must be regularly updated because of continuous antigenic drift and sporadic antigenic shifts in the viral surface glycoproteins. Currently, influenza therapeutics are limited to neuraminidase inhibitors; novel drugs and vaccine approaches are therefore urgently needed. Advances in vaccinology and structural analysis have revealed common antigenic epitopes on hemagglutinins across all influenza viruses and suggest that a universal influenza vaccine is possible. In addition, various immunomodulatory agents and signaling pathway inhibitors are undergoing preclinical development. Continuing challenges in influenza include the emergence of pandemic H1N1 influenza in 2009, human infections with avian H7N9 influenza in 2013, and sporadic human cases of highly pathogenic avian H5N1 influenza. Here, we review the challenges facing influenza scientists and veterinary and human public health officials; we also discuss the exciting possibility of achieving the ultimate goal of controlling influenza's ability to change its antigenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
la Herrán-Arita, A. K. D., Kornum, B. R., Mahlios, J., Jiang, W., Lin, L., Hou, T., Macaubas, C., Einen, M. A., Plazzi, G., Crowe, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007762 · Cited by 105
RetractedEvolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739
Self-citationHuman Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
Smith, G. J. D., Vijaykrishna, D., Bahl, J., Lycett, S. J., Worobey, M., Pybus, O. G., Ma, S. K., Cheung, C. L., Raghwani, J., Bhatt, S., et al. (2009) · Nature · doi:10.1038/nature08182 · Cited by 2,243
Fiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,965
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Herfst, S., Schrauwen, E. J. A., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F., Smith, D. J., et al. (2012) · Science · doi:10.1126/science.1213362 · Cited by 1,665
Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., et al. (2012) · Nature · doi:10.1038/nature10831 · Cited by 1,523
New World Bats Harbor Diverse Influenza A Viruses
Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., Gomez, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003657 · Cited by 1,351
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
(2010) · New England Journal of Medicine · doi:10.1056/nejmra1000449 · Cited by 1,062
(2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03793.x · Cited by 957
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.
Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Hyun Kim, J., Halfmann, P., Hatta, M., et al. (2007) · Nature · doi:10.1038/nature05495 · Cited by 934
Highly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
Antiviral Activity of 1-Adamantanamine (Amantadine)
Davies, W. L., Grunert, R. R., Haff, R. F., McGahen, J. W., Neumayer, E. M., Paulshock, M., Watts, J. C., Wood, T. R., Hermann, E. C., & Hoffmann, C. E. (1964) · Science · doi:10.1126/science.144.3620.862 · Cited by 838
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
γδ T cells: functional plasticity and heterogeneity
Carding, S. R., & Egan, P. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri797 · Cited by 814
Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J., & Fukuda, K. (1998) · Journal of Infectious Diseases · doi:10.1086/515616 · Cited by 704
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698
Hung, I. F., To, K. K., Lee, C.-K., Lee, K.-L., Chan, K., Yan, W.-W., Liu, R., Watt, C.-L., Chan, W.-M., Lai, K.-Y., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq106 · Cited by 678
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Bloom, J. D., Gong, L. I., & Baltimore, D. (2010) · Science · doi:10.1126/science.1187816 · Cited by 649
Koel, B. F., Burke, D. F., Bestebroer, T. M., van der Vliet, S., Zondag, G. C. M., Vervaet, G., Skepner, E., Lewis, N. S., Spronken, M. I. J., Russell, C. A., et al. (2013) · Science · doi:10.1126/science.1244730 · Cited by 632
Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., Krauss, S., Shortridge, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160270697 · Cited by 626
Self-citationStructural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus
Xu, R., Ekiert, D. C., Krause, J. C., Hai, R., Crowe, J. E., & Wilson, I. A. (2010) · Science · doi:10.1126/science.1186430 · Cited by 600
Human Infection with an Avian H9N2 Influenza A Virus in Hong Kong in 2003
Butt, K. M., Smith, G. J. D., Chen, H., Zhang, L. J., Leung, Y. H. C., Xu, K. M., Lim, W., Webster, R. G., Yuen, K. Y., Peiris, J. S. M., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5760-5767.2005 · Cited by 594
Self-citationStructural Basis Of Immune Recognition Of Influenza Virus Hemagglutinin
Wilson, I. (1990) · Annual Review of Immunology · doi:10.1146/annurev.immunol.8.1.737 · Cited by 579
Mechanism of Action of T-705 against Influenza Virus
Furuta, Y., Takahashi, K., Kuno-Maekawa, M., Sangawa, H., Uehara, S., Kozaki, K., Nomura, N., Egawa, H., & Shiraki, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.981-986.2005 · Cited by 546
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Collins, P. J., Haire, L. F., Lin, Y. P., Liu, J., Russell, R. J., Walker, P. A., Skehel, J. J., Martin, S. R., Hay, A. J., & Gamblin, S. J. (2008) · Nature · doi:10.1038/nature06956 · Cited by 534
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Dharan, N. J. (2009) · JAMA · doi:10.1001/jama.2009.294 · Cited by 527
Okuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489
Association of RIG-I with innate immunity of ducks to influenza
Barber, M. R. W., Aldridge, J. R., Webster, R. G., & Magor, K. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001755107 · Cited by 484
Self-citationH9N2 Influenza A Viruses from Poultry in Asia Have Human Virus-like Receptor Specificity
Matrosovich, M. N., Krauss, S., & Webster, R. G. (2001) · Virology · doi:10.1006/viro.2000.0799 · Cited by 464
Self-citationGuo, Y. J., Krauss, S., Senne, D. A., Mo, I. P., Lo, K. S., Xiong, X. P., Norwood, M., Shortridge, K. F., Webster, R. G., & Guan, Y. (2000) · Virology · doi:10.1006/viro.1999.0115 · Cited by 462
Self-citationNitazoxanide: A New Thiazolide Antiparasitic Agent
Fox, L. M., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/428839 · Cited by 443
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
Ward, P., Small, I., Smith, J., Suter, P., & Dutkowski, R. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki018 · Cited by 428
Early administration of oral oseltamivir increases the benefits of influenza treatment
Aoki, F. Y. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg007 · Cited by 424
Babu, Y. S., Chand, P., Bantia, S., Kotian, P., Dehghani, A., El-Kattan, Y., Lin, T.-H., Hutchison, T. L., Elliott, A. J., Parker, C. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002679 · Cited by 384
Monto, A. S., McKimm-Breschkin, J. L., Macken, C., Hampson, A. W., Hay, A., Klimov, A., Tashiro, M., Webster, R. G., Aymard, M., Hayden, F. G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01339-05 · Cited by 364
Self-citationOseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
Meijer, A., Lackenby, A., Hungnes, O., Lina, B., van der Werf, S., Schweiger, B., Opp, M., Paget, J., van de Kassteele, J., Hay, A. J., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1504.081280 · Cited by 362
Influenza virus resistance to neuraminidase inhibitors
Samson, M., Pizzorno, A., Abed, Y., & Boivin, G. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.014 · Cited by 343
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807142105 · Cited by 314
Sensitization and Antibody Formation after Injection of Tubercle Bacilli and Paraffin Oil.
Freund, J., Casals, J., & Hosmer, E. P. (1937) · Experimental Biology and Medicine · doi:10.3181/00379727-37-9625 · Cited by 311
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302
Hyperimmune IV Immunoglobulin Treatment
Hung, I. F. N., To, K. K. W., Lee, C.-K., Lee, K.-L., Yan, W.-W., Chan, K., Chan, W.-M., Ngai, C.-W., Law, K.-I., Chow, F.-L., et al. (2013) · Chest · doi:10.1378/chest.12-2907 · Cited by 286
Wang, Z., Zhang, A., Wan, Y., Liu, X., Qiu, C., Xi, X., Ren, Y., Wang, J., Dong, Y., Bao, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321748111 · Cited by 272
Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift
Treanor, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038238 · Cited by 259
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
Gubareva, L. V. (2004) · Virus Research · doi:10.1016/s0168-1702(04)00133-9 · Cited by 257
Air, G. M. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00304.x · Cited by 246
Schäffr, J. R., Kawaoka, Y., Bean, W. J., Süss, J., Senne, D., & Webster, R. G. (1993) · Virology · doi:10.1006/viro.1993.1319 · Cited by 245
Self-citationH5N1 Hybrid Viruses Bearing 2009/H1N1 Virus Genes Transmit in Guinea Pigs by Respiratory Droplet
Zhang, Y., Zhang, Q., Kong, H., Jiang, Y., Gao, Y., Deng, G., Shi, J., Tian, G., Liu, L., Liu, J., et al. (2013) · Science · doi:10.1126/science.1229455 · Cited by 243
Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection
Malakhov, M. P., Aschenbrenner, L. M., Smee, D. F., Wandersee, M. K., Sidwell, R. W., Gubareva, L. V., Mishin, V. P., Hayden, F. G., Kim, D. H., Ing, A., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1470-1479.2006 · Cited by 233
Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
Hauge, S. H., Dudman, S., Borgen, K., Lackenby, A., & Hungnes, O. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1502.081031 · Cited by 233
Rossignol, J. F., La Frazia, S., Chiappa, L., Ciucci, A., & Santoro, M. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029470 · Cited by 232
Reed, C., Meltzer, M. I., Finelli, L., & Fiore, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.098 · Cited by 228
Identification of H2N3 influenza A viruses from swine in the United States
Ma, W., Vincent, A. L., Gramer, M. R., Brockwell, C. B., Lager, K. M., Janke, B. H., Gauger, P. C., Patnayak, D. P., Webby, R. J., & Richt, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710286104 · Cited by 225
Khurana, S., Loving, C. L., Manischewitz, J., King, L. R., Gauger, P. C., Henningson, J., Vincent, A. L., & Golding, H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006366 · Cited by 223
Luca, G., Haba‐Rubio, J., Dauvilliers, Y., Lammers, G., Overeem, S., Donjacour, C. E., Mayer, G., Javidi, S., Iranzo, A., Santamaria, J., et al. (2013) · Journal of Sleep Research · doi:10.1111/jsr.12044 · Cited by 222
Entry of influenza A virus: host factors and antiviral targets
Edinger, T. O., Pohl, M. O., & Stertz, S. (2014) · Journal of General Virology · doi:10.1099/vir.0.059477-0 · Cited by 215
Bommakanti, G., Citron, M. P., Hepler, R. W., Callahan, C., Heidecker, G. J., Najar, T. A., Lu, X., Joyce, J. G., Shiver, J. W., Casimiro, D. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007465107 · Cited by 214
Korba, B. E., Montero, A. B., Farrar, K., Gaye, K., Mukerjee, S., Ayers, M. S., & Rossignol, J.-F. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.08.005 · Cited by 210
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
Kiso, M., Takahashi, K., Sakai-Tagawa, Y., Shinya, K., Sakabe, S., Le, Q. M., Ozawa, M., Furuta, Y., & Kawaoka, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909603107 · Cited by 207
Yoshida, R., Igarashi, M., Ozaki, H., Kishida, N., Tomabechi, D., Kida, H., Ito, K., & Takada, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000350 · Cited by 201
Ducatez, M., Hause, B. M., Stigger-Rosser, E., Darnell, D., Corzo, C. A., Juleen, K., Simonson, R. R., Brockwell‐Staats, C., Rubrum, A. M., Wang, D., et al. (2011) · Emerging infectious diseases · doi:10.3201/1709.110338 · Cited by 198
Systematic review of influenza resistance to the neuraminidase inhibitors
Thorlund, K., Awad, T., Boivin, G., & Thabane, L. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-134 · Cited by 189
Boon, A. C. M., deBeauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G., Lu, L., Williams, R. W., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00514-09 · Cited by 184
Update: Influenza Activity--United States, 1997-98 Season
(1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.279.7.498-a · Cited by 184
A common solution to group 2 influenza virus neutralization
Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 182
Laver, W. G., Air, G. M., Webster, R. G., Gerhard, W., Ward, C. W., & Dopheide, T. A. A. (1979) · Virology · doi:10.1016/0042-6822(79)90540-3 · Cited by 171
Self-citationOutbreak of Variant Influenza A(H3N2) Virus in the United States
Jhung, M. A., Epperson, S., Biggerstaff, M., Allen, D., Balish, A., Barnes, N., Beaudoin, A., Berman, L., Bidol, S., Blanton, L., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit649 · Cited by 169
A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
Moss, R. B., Hansen, C., Sanders, R. L., HAWLEY, S. B., Li, T., & Steigbigel, R. T. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis622 · Cited by 157
Broadly neutralizing antibodies against influenza virus and prospects for universal therapies
Ekiert, D. C., & Wilson, I. A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.005 · Cited by 155
Influenza Virus Directly Infects Human Natural Killer Cells and Induces Cell Apoptosis
Mao, H., Tu, W., Qin, G., Law, H., Sia, S. F., Chan, P., Liu, Y., Lam, K.-T., Zheng, J. H., Peiris, M. J. S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00805-09 · Cited by 154
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
Nabel, G. J., & Fauci, A. S. (2010) · Nature Medicine · doi:10.1038/nm1210-1389 · Cited by 152
Anti-influenza virus activity of peramivir in mice with single intramuscular injection
Bantia, S., Arnold, C., Parker, C. D., Upshaw, R., & Chand, P. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.10.002 · Cited by 149
Amantadine-Oseltamivir Combination therapy for H5N1 Influenza Virus Infection in Mice
Ilyushina, N. A., Hoffmann, E., Salomon, R., Webster, R. G., & Govorkova, E. A. (2007) · Antiviral Therapy · doi:10.1177/135965350701200302 · Cited by 142
Self-citationA Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 Influenza
Mai, L. Q., Wertheim, H. F. L., Dương, T. N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0910448 · Cited by 136
Immunomodulatory therapy for severe influenza
Darwish, I., Mubareka, S., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.56 · Cited by 136
A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin
Xu, R., Krause, J. C., McBride, R., Paulson, J. C., Crowe, J. E., & Wilson, I. A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2500 · Cited by 135
Yuan, J., Zhang, L., Kan, X., Jiang, L., Yang, J., Guo, Z., & Ren, Q. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit479 · Cited by 131
Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza
Hurt, A. C., Hardie, K., Wilson, N. J., Deng, Y.-M., Maggi Osbourn, B. N., Gehrig, N., & Kelso, A. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1111078 · Cited by 130
Tu, W., Zheng, J. H., Liu, Y., Sia, S. F., Liu, M., Qin, G., Ng, I. H. Y., Xiang, Z., Lam, K.-T., Peiris, M. J. S., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110226 · Cited by 125
Structural basis for oseltamivir resistance of influenza viruses
Collins, P. J., Haire, L. F., Lin, Y., Liu, J., Russell, R. J., Walker, P. A., Martin, S. R., Daniels, R. S., Gregory, V., Skehel, J. J., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.017 · Cited by 121
Family Clustering of Avian Influenza A (H5N1)
Olsen, S. J., Ungchusak, K., Sovann, L., Uyeki, T. M., Dowell, S. F., Cox, N. J., Aldis, W. L., & Chunsuttiwat, S. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.050646 · Cited by 120
Ilyushina, N. A., Hay, A. J., Yılmaz, N., Boon, A. C. M., Webster, R. G., & Govorkova, E. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01579-07 · Cited by 117
Self-citationLevie, K., Leroux‐Roels, I., Hoppenbrouwers, K., Kervyn, A., Vandermeulen, C., Forgus, S., Leroux-Roels, G. G., Pichon, S., & Kusters, I. C. (2008) · The Journal of Infectious Diseases · doi:10.1086/590913 · Cited by 116
Development of cellular signaling pathway inhibitors as new antivirals against influenza
Planz, O. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.008 · Cited by 106
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
Ikematsu, H., & Kawai, N. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.112 · Cited by 101
Inhibition of Human Natural Killer Cell Activity by Influenza Virions and Hemagglutinin
Mao, H., Tu, W., Liu, Y.-P., Qin, G., Zheng, J., Chan, P., Lam, K.-T., Peiris, J. M. M., & Lau, Y.-L. (2010) · Journal of Virology · doi:10.1128/jvi.02340-09 · Cited by 100
Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11
Storms, A. D., Gubareva, L. V., Su, S., Wheeling, J. T., Okomo‐Adhiambo, M., Pan, C., Reisdorf, E. S., George, K. S., Myers, R. A., Wotton, J. T., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1802.111466 · Cited by 97
Zürcher, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl321 · Cited by 97
Nguyen, J. T., Smee, D. F., Barnard, D. L., Julander, J. G., Gross, M. I., de Jong, M. D., & Went, G. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031006 · Cited by 90
H5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load
Boon, A. C. M., Finkelstein, D., Zheng, M., Liao, G., Allard, J. D., Klumpp, K., Webster, R. G., Peltz, G., & Webby, R. J. (2011) · mBio · doi:10.1128/mbio.00171-11 · Cited by 87
Self-citationEmerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1
Renaud, C., Kuypers, J. M., & Englund, J. A. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.05.019 · Cited by 80
Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus Replication
Stachulski, A. V., Pidathala, C., Row, E. C., Sharma, R., Berry, N. G., Iqbal, M., Bentley, J., Allman, S. A., Edwards, G., Helm, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200153p · Cited by 79
Combination Chemotherapy for Influenza
Govorkova, E. A., & Webster, R. G. (2010) · Viruses · doi:10.3390/v2081510 · Cited by 70
Self-citationRisk Assessment of H2N2 Influenza Viruses from the Avian Reservoir
Jones, J. C., Baranovich, T., Marathe, B. M., Danner, A. F., Seiler, J. P., Franks, J., Govorkova, E. A., Krauss, S. L., & Webster, R. G. (2013) · Journal of Virology · doi:10.1128/jvi.02526-13 · Cited by 68
Self-citationBelser, J. A., Davis, C. T., Balish, A. L., Edwards, L. E., Zeng, H., Maines, T. R., Gustin, K. M., Martínez, I. L., Fasce, R., Cox, N. J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00154-13 · Cited by 67
Kim, W., Suh, G. Y., Huh, J. W., Kim, S.-H., Kim, M.-J., Kim, Y. S., Kim, H.-R., Ryu, Y. J., Han, M. S., Ko, Y. G., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05529-11 · Cited by 65
Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure
Wei, C., Yassine, H. M., McTamney, P. M., Gall, J. G. D., Whittle, J. R. R., Boyington, J. C., & Nabel, G. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004273 · Cited by 64
Influenza pandemics: History and lessons learned
Monto, A. S., & Webster, R. G. (2013) · Wiley eBooks · doi:10.1002/9781118636817.ch2 · Cited by 54
Self-citationThe use of sialidase therapy for respiratory viral infections
Nicholls, J. M., Moss, R. B., & Haslam, S. M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.012 · Cited by 46
Thiazolides as Novel Antiviral Agents. 2. Inhibition of Hepatitis C Virus Replication
Stachulski, A. V., Pidathala, C., Row, E. C., Sharma, R., Berry, N. G., Lawrenson, A. S., Moores, S. L., Iqbal, M., Bentley, J., Allman, S. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201264t · Cited by 44
Comment on “Seroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis”
Kerkhove, M. D. V., Riley, S., Lipsitch, M., Guan, Y., Monto, A. S., Webster, R. G., Zambon, M. C. F. A., Nicoll, A., Peiris, M. J. S., & Ferguson, N. M. (2012) · Science · doi:10.1126/science.1221434 · Cited by 34
Self-citationAntivirals in seasonal and pandemic influenza—future perspectives*
Wathen, M. W., Barro, M., & Bright, R. A. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12049 · Cited by 30
Houng, H. H., Garner, J. L., Zhou, Y., Lyons, A. G., Kuschner, R. A., Deye, G. A., Clair, K. J. S., Douce, R. W., Chicaiza, W., Blair, P. J., et al. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.09.004 · Cited by 28
Emulsion-Based Adjuvants for Improved Influenza Vaccines
O’Hagan, D. T., Tsai, T. F., & Reed, S. G. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0279-2_14 · Cited by 22
Koopmans, M., Fouchier, R. A. M., Wilbrink, B., et al. (2003) · Weekly releases (1997–2007) · doi:10.2807/esw.07.18.02217-en · Cited by 19
Universal Flu Vaccines: Primum non nocere
Crowe, J. E. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007118 · Cited by 17
Klenk, H. D., Garten, W., & Matrosovich, M. N. (2013) · Wiley eBooks · doi:10.1002/9781118636817.ch10 · Cited by 7
Cited by
Drug resistance in influenza A virus: the epidemiology and management
Hussain, M., Galvin, H., Haw, T. Y., Nutsford, A., & Husain, M. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s105473 · Cited by 439
Evolution of Influenza A Virus by Mutation and Re-Assortment
Shao, W., Li, X., Goraya, M., Wang, S., & Chen, J.-L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081650 · Cited by 427
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz-Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 402
Abd El-Aziz, T. M., & Stockand, J. D. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104327 · Cited by 363
The evolution and future of influenza pandemic preparedness
Harrington, W. N., Kackos, C. M., & Webby, R. J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00603-0 · Cited by 279
Metadata
- Authors
- Webster, R. G., & Govorkova, E. A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2014-05-30
- Volume
- 1323
- Issue
- 1
- Pages
- 115-139
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2117386204
- Cited by
- 399
- References
- 116
- FWCI
- 20.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.